Tuesday 16th, January 2018
canara news

Reflux drugs may up kidney disease risk

Published On : 09 Nov 2017

New York,(IANS) Regular use of drugs that are commonly used to treat heartburn, acid reflux and ulcers may increase the risk of kidney disease, a study has claimed.

According to the study, regular use of proton pump inhibitors (PPIs) like pantoprazole or rabeprazole -- the most commonly prescribed medications worldwide to reduce gastric acid production -- have a potential to increase the risk of chronic kidney disease or kidney failure.

To investigate the association, researchers led by Charat Thongprayoon from Bassett Medical Centre in New York, US conducted a meta-analysis of five studies with 536,902 participants.

The results showed that individuals who used PPIs had a 33 per cent increased relative risk of chronic kidney disease (CKD) or kidney failure when compared with non-users.

"This study demonstrates a significant association between the use of PPIs and increased risks of chronic kidney disease and kidney failure," Thongprayoon said.

"Although no causal relationship has been proven, providers should consider whether PPI therapy is indicated for patients. Chronic use of PPIs should be avoided if not really indicated," Thongprayoon added.

The findings of the analysis will be presented at ASN Kidney Week 2017 in New Orleans.

In a recent study, published in the journal Gut, PPIs users were found to be twice at risk of developing stomach cancer.

The study led by researchers from the University of Hong Kong revealed that daily use of PPIs were linked to more than quadrupling in risk of stomach cancer (4.55) compared with weekly use.

The "clear dose-response and time response trend" in the use of PPIs and stomach cancer risk, suggests that doctors "should exercise caution when prescribing long-term PPIs...", the researchers noted.

More News

How gut bacteria, broccoli can help keep bowel cancer away
How gut bacteria, broccoli can help keep bowel cancer away
  Protein linked to postpartum depression identified
Protein linked to postpartum depression identified
Arthritis drug may be new hope for skin cancer
Arthritis drug may be new hope for skin cancer

Write your Comments

Disclaimer: Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. canaranews.com will not be responsible for any defamatory message posted under this article.

Please note that under 66A of the IT Act, sending offensive or menacing messages through electronic communication service and sending false messages to cheat, mislead or deceive people or to cause annoyance to them is punishable. It is obligatory on CANARANEWS to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using canaranews will be purely at your own risk, and in no way will canaranews.com be held responsible.